BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21834067)

  • 1. Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: role of the nuclear interferon regulatory factor 1-NF-κB-c-jun complex.
    Marotte H; Tsou PS; Rabquer BJ; Pinney AJ; Fedorova T; Lalwani N; Koch AE
    Arthritis Rheum; 2011 Nov; 63(11):3253-62. PubMed ID: 21834067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A.
    Marotte H; Ahmed S; Ruth JH; Koch AE
    Arthritis Rheum; 2010 Mar; 62(3):722-31. PubMed ID: 20131228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
    Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
    Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F2 directly regulates the STAT1 and PI3K/AKT/NF-κB pathways to exacerbate the inflammatory phenotype in rheumatoid arthritis synovial fibroblasts and mouse embryonic fibroblasts.
    Wang S; Wang L; Wu C; Sun S; Pan JH
    Arthritis Res Ther; 2018 Oct; 20(1):225. PubMed ID: 30286793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis.
    Wang L; Song G; Zheng Y; Tan W; Pan J; Zhao Y; Chang X
    Arthritis Res Ther; 2015 Aug; 17(1):227. PubMed ID: 26303122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts.
    Mun SH; Kim JW; Nah SS; Ko NY; Lee JH; Kim JD; Kim DK; Kim HS; Choi JD; Kim SH; Lee CK; Park SH; Kim BK; Kim HS; Kim YM; Choi WS
    Arthritis Rheum; 2009 Mar; 60(3):678-85. PubMed ID: 19248119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis.
    Zhang HG; Hyde K; Page GP; Brand JP; Zhou J; Yu S; Allison DB; Hsu HC; Mountz JD
    Arthritis Rheum; 2004 Feb; 50(2):420-31. PubMed ID: 14872484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V; Elewaut D; Bougarne N; Bracke D; Van Calenbergh S; Haegeman G; De Bosscher K
    Arthritis Rheum; 2009 Nov; 60(11):3241-50. PubMed ID: 19877072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts.
    Luo SF; Fang RY; Hsieh HL; Chi PL; Lin CC; Hsiao LD; Wu CC; Wang JS; Yang CM
    Arthritis Rheum; 2010 Jan; 62(1):105-16. PubMed ID: 20039412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis.
    Hwang SJ; Choi B; Kang SS; Chang JH; Kim YG; Chung YH; Sohn DH; So MW; Lee CK; Robinson WH; Chang EJ
    Arthritis Res Ther; 2012 Jan; 14(1):R14. PubMed ID: 22264405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibition.
    Marotte H; Tsou PS; Fedorova T; Pinney AJ; Lewis B; Koch AE
    Arthritis Res Ther; 2014 Apr; 16(2):R102. PubMed ID: 24762050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor α-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-κB signaling.
    Trenkmann M; Brock M; Gay RE; Michel BA; Gay S; Huber LC
    Arthritis Rheum; 2013 Apr; 65(4):916-27. PubMed ID: 23280137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.
    Lee A; Qiao Y; Grigoriev G; Chen J; Park-Min KH; Park SH; Ivashkiv LB; Kalliolias GD
    Arthritis Rheum; 2013 Apr; 65(4):928-38. PubMed ID: 23335080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2.
    Xue M; Shen K; McKelvey K; Li J; Chan YK; Hatzis V; March L; Little CB; Tonkin M; Jackson CJ
    Arthritis Res Ther; 2014 Feb; 16(1):R44. PubMed ID: 24495480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.
    Xue M; Chan YK; Shen K; Dervish S; March L; Sambrook PN; Jackson CJ
    Arthritis Rheum; 2012 Jan; 64(1):88-98. PubMed ID: 21905006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.
    Georganas C; Liu H; Perlman H; Hoffmann A; Thimmapaya B; Pope RM
    J Immunol; 2000 Dec; 165(12):7199-206. PubMed ID: 11120852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
    Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
    Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways.
    Filer A; Bik M; Parsonage GN; Fitton J; Trebilcock E; Howlett K; Cook M; Raza K; Simmons DL; Thomas AM; Salmon M; Scheel-Toellner D; Lord JM; Rabinovich GA; Buckley CD
    Arthritis Rheum; 2009 Jun; 60(6):1604-14. PubMed ID: 19479862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.